Michael Pearson, ex-CEO of Valeant Pharmaceuticals, is suing the embattled drugmaker for refusing to pay him more than 3 million company shares that he said he is owed.
WSJ.com: Health, Wall Street Journal: Business: Health
Mon, 03/27/2017 - 3:02pm